scholarly article | Q13442814 |
P2093 | author name string | Carlson J | |
Setchell KD | |||
Barnes S | |||
Grubbs C | |||
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 239-253 | |
P577 | publication date | 1990-01-01 | |
P1433 | published in | Progress in Clinical and Biological Research | Q26842355 |
P1476 | title | Soybeans inhibit mammary tumors in models of breast cancer | |
P478 | volume | 347 |
Q37164347 | A Bowman-Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition |
Q72030104 | A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids |
Q44908026 | Analysis of isoflavone contents in vegetable soybeans |
Q51788593 | Beneficial effects of soy protein in the initiation and progression against dimethylbenz [a] anthracene-induced breast tumors in female rats. |
Q36089800 | Development of estimation methods of skin oxidation and evaluation of anti-oxidative effects of genistein in topical formulations |
Q36802805 | Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells |
Q33889019 | Flavonoids and age-related disease: risk, benefits and critical windows |
Q72013145 | Genetic damage and the inhibition of 7,12-dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice |
Q42796358 | Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[α]anthracene-induced rat mammary tumor model |
Q34941433 | Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays |
Q28387066 | Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease |
Q42944121 | Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol |
Q38763988 | Mass spectrometric evidence for the modification of small molecules in a cobalt-60-irradiated rodent diet. |
Q42440089 | Phenoxodiol, a novel isoflavone derivative, inhibits dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female Sprague–Dawley rats |
Q35119194 | Phyto-oestrogens and osteoporosis: what is a safe dose? |
Q34832063 | Phytoestrogens are partial estrogen agonists in the adult male mouse |
Q34831826 | Phytoestrogens: epidemiology and a possible role in cancer protection |
Q35335557 | Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk |
Q36744585 | Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary |
Q91892351 | Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells |
Q30837716 | Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells |
Q24628910 | The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer |
Q43199168 | The phytoestrogen content of rodent diets |
Q28343395 | The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function |
Q44510436 | Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells |
Search more.